Austin Dermatology Associates

Austin, Texas 78705

0 studies enrolling now · 12 studies all time

What they study most

Acne Vulgaris, Atopic Dermatitis, Onychomycosis, Plaque Psoriasis, Plaque Type Psoriasis, Psoriasis, Psoriatic Arthritis

Studies at this site

• Phase II Trial of RA-18C3 in Subjects With Moderate to Severe Acne Vulgaris — Completed
• Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 1 (ECZema TRAlokinumab Trial no. 1) — Completed
• Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis. — Completed
• Study to Evaluate Effectiveness and Safety in Subjects With Moderate to Severe Psoriasis — Completed
• A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis — Completed
• A Study of the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate to Severe Plaque Psoriasis of the Scalp — Completed
• PALACE 3: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis — Completed
• A Study to Evaluate the Comparative Efficacy of CNTO 1959 (Guselkumab) and Secukinumab for the Treatment of Moderate to Severe Plaque-type Psoriasis — Completed
• Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira — Completed
• Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis — Completed
• A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis — Completed
• Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis — Completed